BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9349331)

  • 1. Multiparameter flow cytometry as a tool to evaluate antipsoriatic therapy.
    Glade CP; van Erp PE; Boezeman JB; van de Kerkhof PC
    Br J Dermatol; 1997 Sep; 137(3):367-75. PubMed ID: 9349331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation.
    Glade CP; van Erp PE; van Hooijdonk CA; Elbers ME; van de Kerkhof PC
    Acta Derm Venereol; 1995 Sep; 75(5):381-5. PubMed ID: 8615058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
    van Erp PE; Rijzewijk JJ; Boezeman JB; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof PC; Ramaekers FC; Bauer FW
    Am J Pathol; 1989 Nov; 135(5):865-70. PubMed ID: 2479273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
    Mommers JM; Goossen JW; van De Kerkhof PC; van Erp PE
    Cytometry; 2000 Feb; 42(1):43-9. PubMed ID: 10679742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring hyperproliferative disorders in human skin: flow cytometry of changing cytokeratin expression.
    Franssen ME; Boezeman JB; Van De Kerkhof PC; Van Erp PE
    Cytometry B Clin Cytom; 2004 Jan; 57(1):32-9. PubMed ID: 14696061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiparameter flow cytometric analysis of the effect of bexarotene on the epidermis of the psoriatic lesion.
    Franssen ME; Smit JV; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 2003 Sep; 149(3):506-12. PubMed ID: 14510982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis.
    Lin YK; Wong WR; Chang YC; Chang CJ; Tsay PK; Chang SC; Pang JH
    Dermatology; 2007; 214(2):155-61. PubMed ID: 17341866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M; Mrowietz U; Koenig M; Simon JC
    Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of long-term treatment with tacalcitol on the psoriatic epidermis. A flow cytometric analysis.
    Mommers JM; Castelijns FA; Seegers BA; Van Rossum MM; Van Hooijdonk CA; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1998 Sep; 139(3):468-71. PubMed ID: 9767292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogs.
    van de Kerkhof PC
    J Investig Dermatol Symp Proc; 1996 Apr; 1(1):78-81. PubMed ID: 9627698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation.
    Körver JE; Vissers WH; van Rens DW; Pasch MC; van Erp PE; Boezeman JB; van De Kerkhof PC
    Br J Dermatol; 2007 Jan; 156(1):130-7. PubMed ID: 17199579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
    Körver JE; van Duijnhoven MW; Pasch MC; van Erp PE; van de Kerkhof PC
    Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
    Smit JV; de Jong EM; van Hooijdonk CA; Otero ME; Boezeman JB; van de Kerkhof PC
    J Am Acad Dermatol; 2004 Aug; 51(2):257-64. PubMed ID: 15280845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle kinetics in normal human skin by in vivo administration of iododeoxyuridine and application of a differentiation marker--implications for cell cycle kinetics in psoriatic skin.
    van Erp PE; Boezeman JB; Brons PP
    Anal Cell Pathol; 1996 Jun; 11(1):43-54. PubMed ID: 8844104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
    Vissers WH; van Vlijmen I; van Erp PE; de Jong EM; van de Kerkhof PC
    Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparameter flow cytometric characterization of epidermal cell suspensions prepared from normal and hyperproliferative human skin using an optimized thermolysin-trypsin protocol.
    Glade CP; Seegers BA; Meulen EF; van Hooijdonk CA; van Erp PE; van de Kerkhof PC
    Arch Dermatol Res; 1996 Apr; 288(4):203-10. PubMed ID: 8967793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow-cytometric characterization of normal versus psoriatic epidermis using improved cell separation methodology.
    Seegers BA; Glade CP; van Hooijdonk CA; van Erp PE; de Jongh GJ; van de Kerkhof PC
    Exp Dermatol; 2000 Aug; 9(4):266-70. PubMed ID: 10949548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.